References
- Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966;26:751–61
- Canick JA, Knight GJ, Palomaki GE, et al. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down’s syndrome. Br J Obstet Gynaecol 1988;95:330–3
- ACOG. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–27
- Morris RK, Cnossen JS, Langejans M, et al. Serum screening with Down’s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth 2008;8:33
- Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;30:918–49
- Jelliffe-Pawlowski LL, Shaw GM, Currier RJ, et al. Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers. Am J Obstet Gynecol 2013;208:492–11
- Duric K, Skrablin S, Lesin J, et al. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol 2003;110:12–15
- Yeast JD, Lu G. Biochemical markers for the prediction of preterm delivery. Clin Perinatol 2007;34:573–86. vi
- Olsen RN, Dunsmoor-Su R, Capurro D, et al. Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol. J Matern Fetal Neonatal Med 2014;27:376–80
- Wanapirak C, Sirichotiyakul S, Luewan S, et al. Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group. J Obstet Gynaecol Res 2012;38:686–91
- Tongsong T, Simaraks S, Sirivatanapa P, et al. Study of intrauterine growth from birthweight at Maharaj Nakhon Chiang Mai Hospital. J Med Assoc Thai 1993;76:482–6
- Hausknecht RU. Estriol and fetal health. Obstet Gynecol 1967;30:639–45
- Milunsky A, Nebiolo L. Maternal serum triple analyte screening and adverse pregnancy outcome. Fetal Diagn Ther 1996;11:249–53
- Santolaya-Forgas J, Jessup J, Burd LI, et al. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol. J Reprod Med 1996;41:87–90
- Schleifer RA, Bradley LA, Richards DS, Ponting NR. Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening. Am J Obstet Gynecol 1995;173:1152–6
- Jelliffe-Pawlowski LL, Baer RJ, Currier RJ. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies. Prenat Diagn 2010;30:727–33
- Yaron Y, Cherry M, Kramer RL, et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968–74
- Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 2000;96:321–7